Corebridge director receives 6,553 deferred stock units
Lynch Christopher S. reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Lynch Christopher S. reported acquisition or exercise transactions in this Form 4 filing.
Corebridge Financial, Inc. director Christopher S. Lynch received an award of 6,553 deferred stock units (DSUs) of common stock as a compensation grant. The DSUs were issued at no cash cost and increase his holdings to 34,962 DSUs, each convertible into one share when his board service ends.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 6,553 | $0.00 | $0.00 |
Footnotes (2)
- F1. Reflects deferred stock units (DSUs) granted under the Corebridge Financial, Inc. 2022 Omnibus Incentive Plan exempt under Rule 16b-3. Each DSU represents a right to receive one share of common stock of the Issuer upon the director's termination of service.
- F2. Includes 34,962 DSUs.
Key Figures
Key Terms
deferred stock units (DSUs) financial
2022 Omnibus Incentive Plan financial
Rule 16b-3 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Corebridge Financial (CRBG) report in this Form 4?
How many Corebridge Financial (CRBG) units does Christopher Lynch hold after this grant?
Was cash involved in Christopher Lynch’s Corebridge Financial (CRBG) Form 4 transaction?
What are deferred stock units (DSUs) in the Corebridge Financial (CRBG) filing?
Under what plan were the Corebridge Financial (CRBG) DSUs granted to Christopher Lynch?
AI-generated analysis. How Rhea-AI works. Not financial advice.